[1] |
Weyers W, Weyers I, Bonczkowitz M, et al. Lichen amyloidosus: a consequence of scratching[J]. J Am Acad Dermatol, 1997, 37(6): 923⁃928.
|
[2] |
Lin MW, Lee DD, Lin CH, et al. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23[J]. Br J Dermatol, 2005, 152(1): 29⁃36. DOI: 10.1111/j.1365⁃2133.2004.06254.x.
|
[3] |
Lin MW, Lee DD, Liu TT, et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis[J]. Eur J Hum Genet, 2010, 18(1): 26⁃32. DOI: 10.1038/ejhg.2009.135.
|
[4] |
Lee DD, Lin MW, Chen IC, et al. Genome⁃wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1⁃q11.2[J]. Br J Dermatol, 2006, 155(6): 1201⁃1208. DOI: 10.1111/j.1365⁃2133.2006.07524.x.
|
[5] |
Arita K, South AP, Hans⁃Filho G, et al. Oncostatin M receptor⁃beta mutations underlie familial primary localized cutaneous amyloidosis[J]. Am J Hum Genet, 2008, 82(1): 73⁃80. DOI: 10.1016/j.ajhg.2007.09.002.
|
[6] |
Finelt N, Gazel A, Gorelick S, et al. Transcriptional responses of human epidermal keratinocytes to Oncostatin⁃M[J]. Cytokine, 2005, 31(4): 305⁃313. DOI: 10.1016/j.cyto.2005.05.005.
|
[7] |
Tanaka A, Arita K, Lai⁃Cheong JE, et al. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis[J]. Br J Dermatol, 2009, 161(6): 1217⁃1224. DOI: 10.1111/j.1365⁃2133.2009.09311.x.
|
[8] |
Davies FE, Raje N, Hideshima T, et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma[J]. Blood, 2001, 98(1): 210⁃216.
|
[9] |
Timmermann A, Küster A, Kurth I, et al. A functional role of the membrane⁃proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor[J]. Eur J Biochem, 2002, 269(11): 2716⁃2726.
|
[10] |
Qi XP, Zhao JQ, Chen ZG, et al. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D[J]. Oncotarget, 2015, 6(32): 33993⁃34003. DOI: 10.18632/oncotarget.4992.
|
[11] |
Saeedi M, Ebrahim⁃Habibi A, Haghighi A, et al. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis[J]. Biomed Res Int, 2014, 2014: 653724. DOI: 10.1155/2014/653724.
|
[12] |
Wang WH, Li LF, Huang ES, et al. A new c.1845A→T of oncostatin M receptor⁃β mutation and slightly enhanced oncostatin M receptor⁃β in a Chinese family with primary localized cutaneous amyloidosis[J]. Eur J Dermatol, 2012, 22(1): 29⁃33. DOI: 10.1684/ejd.2011.1565.
|
[13] |
Tanaka A, Lai⁃Cheong JE, van den Akker PC, et al. The molecular skin pathology of familial primary localized cutaneous amyloidosis[J]. Exp Dermatol, 2010, 19(5): 416⁃423. DOI: 10.1111/j.1600⁃0625.2010.01083.x.
|
[14] |
周云, 曹先伟, 许桂文, 等. 家族性原发性皮肤淀粉样变一家系的OSMR基因突变检测[J]. 中华皮肤科杂志, 2014, 47(8): 591⁃592. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.08.017.
|
[15] |
Babilas P, Fiebig BS, Aslanidis C, et al. Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis[J]. Br J Dermatol, 2009, 161(4): 944⁃947. DOI: 10.1111/j.1365⁃2133.2009.09237.x.
|